{"database": "press", "table": "releases", "rows": [["https://davids.house.gov/media/press-releases/icymi-davids-touts-federal-law-lower-insulin-costs-kansans", "ICYMI: Davids Touts Federal Law to Lower Insulin Costs for Kansans", "2023-08-18", "2023", "2023-08", "Democrat", "House", "KS", "Sharice Davids", "D000629", "davids.house.gov", "davids", "https://davids.house.gov/media/press-releases", "scraper", "This week, Representative Sharice Davids released a special report on how federal legislation is lowering the cost of insulin in Kansas\u2019 Third District. Thanks to the Inflation Reduction Act\u2019s $35 price cap, Kansans on Medicare are saving an average of $620 annually on insulin compared to 2020. People with private insurance and those who are uninsured are also seeing drastically lower costs after drug manufacturers lowered costs to match the popular federal policy.\n\nImage\n\nImage\n\nRep. Sharice Davids\u2019 new insulin report that shows drastic decreases in monthly insulin prices because of recent federal legislation.\n\nThe Kansas Reflector reported on Davids\u2019 work to lower insulin costs:\n\n\u201c\u2018For too long,\u2019 Davids said, \u2018Kansans have been forced to pay extremely high prices for insulin while drug companies rake in massive profits.\u2019\n\n[\u2026]\n\n\u201cThat led the Democrat to support passage one year ago of the Inflation Reduction Act, which included provisions making health care more affordable for seniors. At the start of this year, the federal law capped the out-of-pocket cost of insulin for people enrolled in Medicare\u2019s prescription drug plan at $35 for a one-month supply. It also imposed a requirement insulin manufacturers pay a rebate to Medicare if their prices grew faster than inflation.\n\n\u201cUnder pressure from consumers eager for an affordable supply of insulin, the three drug companies dominating the U.S. market agreed to extend the $35 cap to people with private health insurance.\n\n\u201cHad the Inflation Reduction Act been in place in 2020, about 15,000 Kansas residents would have saved an estimated $650 annually on out-of-pocket costs.\n\n[\u2026]\n\n\u201cAt the one-year mark, Davids said the law held great promise for growing the U.S. economy and dealing with climate change. She said health care pieces of the law succeeded in lowering the burden on thousands of Kansans and illustrated the need to push ahead with mandates capping the price for all insulin users.\n\n\u201c\u2018I voted for this historic legislation to lower costs for Kansas families,\u2019 she said. \u2018The law is lowering health care costs, growing the middle class with new clean energy and manufacturing jobs, and making the largest investment in the fight against climate change in our nation\u2019s history.\u2019\u201d\n\nBackground:\n\nDavids released her first insulin report in 2019, which found that Americans paid 5 times more for insulin than people living overseas. In her new report, Davids highlights how recent federal legislation is drastically lowering the cost of insulin for Kansans. Specifically, it finds:\n\nNationally, four million Medicare beneficiaries will together save $760 million a year thanks to the $35 insulin price cap.\n\nKansans on Medicare using insulin will save an average $620 annually on their insulin.\n\n7,100 Kansans in the Third District who are insured through their employer and use insulin will see significant savings due to manufacturer price reductions.\n\n530 Kansans in the Third District who are uninsured and use insulin will see significant savings due to manufacturer price reductions.\n\nAs shown in Davids\u2019 updated insulin report, the Inflation Reduction Act is already lowering health care costs for Kansans. Along with the $35 insulin price cap for Medicare beneficiaries, the law:", 1, "2026-03-30T01:40:41Z", "2026-04-08T00:30:18Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://davids.house.gov/media/press-releases/icymi-davids-touts-federal-law-lower-insulin-costs-kansans"], "units": {}, "query_ms": 1.3128139544278383, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}